BillionToOne Inc.

1 clinical trials · Sponsor

Record	Firm	Date
The ADVANCE (Assay Development and Validation for Pre-Natal and Obstetric Conditions) Study is the Largest U.S.-Based Prospective Study Demonstrating a Circulating Fetal Cell (CFC) Based Approach to Non-invasive Fetal Risk Assessment (NCT07643896)	BillionToOne Inc.	2026-01-10

Every clearance here is in the API, with alerts when new ones post.